Page last updated: 2024-08-16

ribavirin and Infections, Helicobacter

ribavirin has been researched along with Infections, Helicobacter in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ananyan, S; Gemilyan, M; Hakobyan, G1
Huarte, MP; Lacruz, B; Quispe, I; Tiberio, G; Torroba, L1
Akamatsu, T; Ichijo, T; Kiyosawa, K; Matsumoto, A; Muto, H; Tanaka, E; Umemura, T; Yoshizawa, K1

Trials

1 trial(s) available for ribavirin and Infections, Helicobacter

ArticleYear
Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.
    Journal of viral hepatitis, 2007, Volume: 14, Issue:1

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Platelet Count; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome

2007

Other Studies

2 other study(ies) available for ribavirin and Infections, Helicobacter

ArticleYear
Long-term familial Mediterranean fever remission on successful hepatitis C virus treatment in a patient not responding to colchicine: a case report.
    Journal of medical case reports, 2018, May-18, Volume: 12, Issue:1

    Topics: Antiviral Agents; Colchicine; Drug Therapy, Combination; Familial Mediterranean Fever; Female; Helicobacter Infections; Hepatitis C, Chronic; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tubulin Modulators; Young Adult

2018
[Helicobacter cinaedi-associated bacteremia in hepatitis C patient under triple therapy].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:2

    Topics: Antiviral Agents; Bacteremia; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opportunistic Infections; Recombinant Proteins; Ribavirin

2015